ELVIS, it seems, has entered the operating room. 

This new analysis of the ODYSSEY OUTCOMES trial includes data from more than 18,000 patients. 

The ThyrAMI-2 trial tracked 95 patients for 52 weeks of treatment. 

The wearable devices were designed to detect such conditions as cardiovascular disease, coronary artery disease and ischemic heart disease.

Researchers have developed what they believe is the world’s smallest imaging device, a microscopic endoscope capable of scanning the inside of blood vessels.

“Diseases don't respect geographic and political boundaries," wrote ACC President Athena Poppas, MD, and others. 

“This case should be taken into consideration as blood donation policies are being crafted," the researchers wrote. 

In February and March 2020, the inevitable happened: COVID-19 came to the United States, hitting the country’s healthcare system like a 10-pound sledgehammer. 

There’s good news and bad news from the COVID-19 beat. For the bad news, look anywhere news is disseminated. For the good, start with this compact but formidable roundup.  

Korean researchers tested the traditional LI-RADS algorithm and a modified version in nearly 140 patients with liver cancer, sharing their findings in Radiology.

Less than half the U.S. public is OK with physicians giving hospital patients’ names to hospital development departments—and that’s after the doctors ask the patients for permission.